Health impact and economic analysis of NGO-supported neurosurgery in Bolivia
Authors:
- 1 April 2014
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Spine
- Vol. 20 (4) , 436-442
Abstract
Bolivia, one of the poorest countries in the world, ranks 108th on the 2013 Human Development Index. With approximately 1 neurosurgeon per 200,000 people, access to neurosurgery in Bolivia is a growing health concern. Furthermore, neurosurgery in nonindustrialized countries has been considered both cost-prohibitive and lacking in outcomes evaluation. A non-governmental organization (NGO) supports spinal procedures in Bolivia (Solidarity Bridge), and the authors sought to determine its impact and cost-effectiveness. In a retrospective review of prospectively collected data, 19 patients were identified prior to spinal instrumentation and followed over 12 months. For inclusion, patients required interviewing prior to surgery and during at least 2 follow-up visits. All causes of spinal pathology were included. Sixteen patients met inclusion criteria and were therefore part of the analysis. Outcomes measured included assessment of activities of daily living, pain, ambulation, return to work/school, and satisfaction. Cost-effectiveness was determined by cost-utility analysis. Utilities were derived using the Health Utilities Index. Complications were incorporated into an expected value decision tree. Median (± SD) preoperative satisfaction was 2.0 ± 0.3 (on a scale of 0-10), while 6-month postoperative satisfaction was 7 ± 1.4 (p < 0.0001). Ambulation, pain, and emotional disability data suggested marked improvement (56%, 69%, and 63%, respectively; p = 0.035, 0.003, and 0.006). Total discounted incremental quality-adjusted life year (QALY) gain was 0.771. The total discounted cost equaled $9036 (95% CI $8561-$10,740) at 2 years. Computing the incremental cost-effectiveness ratio resulted in a value of $11,720/QALY, ranging from $9220 to $15,473/QALY in a univariate sensitivity analysis. This NGO-supported spinal instrumentation program in Bolivia appears to be cost-effective, especially when compared with the conventional $50,000/QALY benchmark and the WHO endorsed country-specific threshold of $16,026/QALY. However, with a gross domestic product per capita in Bolivia equaling $4800 per year and 30.3% of the population living on less than $2 per day, this cost continues to appear unrealistic. Additionally, the study has several significant limitations, namely its limited sample size, follow-up period, the assumption that patients not receiving surgical intervention would not make any clinical improvement, the reliance on the NGO for patient selection and sustainable practices such as follow-up care and ancillary services, and the lack of a randomized prospective design. These limitations, as well as an unclear understanding of Bolivian willingness-to-pay data, affect the generalizability of the study findings and impede widespread economic policy reform. Because cost-effectiveness research may inevitably direct care decisions and prove that an effort such as this can be cost saving, a prospective, properly controlled investigation is now warranted.Keywords
This publication has 22 references indexed in Scilit:
- Revisiting health policy and the World Bank in BoliviaGlobal Social Policy, 2011
- Cost-Effectiveness of the Boston KeratoprosthesisAmerican Journal of Ophthalmology, 2010
- Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational studyBMJ, 2007
- Calculating QALYs, comparing QALY and DALY calculationsHealth Policy and Planning, 2006
- Cost-effectiveness of Pediatric Heart TransplantationThe Journal of Heart and Lung Transplantation, 2006
- Quality of Life Assessment with the Medical Outcomes Study Short Form-36 among Patients with Cervical Spondylotic MyelopathyNeurosurgery, 2003
- The Cost-Effectiveness of Magnetic Resonance Imaging for Patients with Equivocal Neurological SymptomsInternational Journal of Technology Assessment in Health Care, 1997
- Explaining Distortions in Utility Elicitation through the Rank-dependent Model for Risky ChoicesMedical Decision Making, 1995
- Cost utility analysis: What should be measured?Social Science & Medicine, 1994
- Incorporating Utility-Based Quality-of-Life Assessment Measures in Clinical TrialsMedical Care, 1989